-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Initiates Coverage On Coya Therapeutics with Buy Rating, Announces Price Target of $12

Benzinga·06/05/2026 10:29:16
Listen to the news
Roth Capital analyst Boobalan Pachaiyappan initiates coverage on Coya Therapeutics (NASDAQ:COYA) with a Buy rating and announces Price Target of $12.